The following announcement is distributed on behalf of the Irving Institute for Clinical and Translational Research
2023 Trial Innovation Network (TIN) Lecture Series
“Brain Tumors: Challenges and Opportunities in Clinical Trial Design”
Speaker:
Andrew B. Lassman, MS, MD
John Harris Professor of Neurology at Columbia University Medical Center
Medical Director, Trial Innovation Network, Irving Institute for Clinical and Translational Research
Chief, Neuro-Oncology Division, Department of Neurology
Associate Dean of Clinical Research Compliance, Vagelos College of Physicians & Surgeons
Associate Director for Clinical Trials, Herbert Irving Comprehensive Cancer Center
Attending Neurologist, NewYork-Presbyterian Hospital
Dr. Lassman has particular expertise in designing and leading early- and late-phase prospective clinical trials, dedicated to improving the understanding of primary and metastatic brain cancers. His research expands available therapies through translational clinical trials, focused on precision medicine and immunotherapy, and educating the next generation of leaders in the field. Dr. Lassman has recently accepted the role of Scientific Director of the Network Capacity Resource in the Irving Institute for Clinical and Translational Research and the role of Medical Director of the Trial Innovation Network, one of the components of Network Capacity. In his lecture today he will discuss GBM (glioblastoma) clinical trials in addition to several interesting methodological advances in brain tumor trials.
Wednesday, February 15, 2023, from 2:00 – 3:00 PM
Virtual seminar via Zoom
Registration is required:
https://events.columbia.edu/go/PMseminar
For questions contact [email protected]
Accelerating Discoveries Toward Better Health
irvinginstitute.columbia.edu
